Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension

Rationale: Although amphetamines are recognized as “likely” agents to cause drug- and toxin-associated pulmonary arterial hypertension (PAH), (meth)amphetamine-associated PAH (Meth-APAH) has not been well described. Objectives: To prospectively characterize the clinical presentation, histopathology,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Crit Care Med
Main Authors: Zamanian, Roham T., Hedlin, Haley, Greuenwald, Paul, Wilson, David M., Segal, Joshua I., Jorden, Michelle, Kudelko, Kristina, Liu, Juliana, Hsi, Andrew, Rupp, Allyson, Sweatt, Andrew J., Tuder, Rubin, Berry, Gerald J., Rabinovitch, Marlene, Doyle, Ramona L., de Jesus Perez, Vinicio, Kawut, Steven M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855067/
https://ncbi.nlm.nih.gov/pubmed/28934596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201705-0943OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados